tiprankstipranks
Advertisement
Advertisement

AUPH Stock Latest News

Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune Pipeline
Company AnnouncementsAurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune Pipeline
12d ago
8K
AUPH
Kezar Life Sciences takeover valuation ‘makes sense,’ says Jefferies
PremiumThe Fly
Kezar Life Sciences takeover valuation ‘makes sense,’ says Jefferies
16d ago
KZR
AUPH
Midday Fly By: Sysco buying Restaurant Depot, Uber to acquire Blacklane
PremiumThe Fly
Midday Fly By: Sysco buying Restaurant Depot, Uber to acquire Blacklane
16d ago
IQ
SR
Aurinia to Buy Kezar Life Sciences in Cash-and-CVR Autoimmune Deal
PremiumCompany Announcements
Aurinia to Buy Kezar Life Sciences in Cash-and-CVR Autoimmune Deal
16d ago
AUPH
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
PremiumThe Fly
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
16d ago
KZR
AUPH
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
PremiumThe FlyAurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
16d ago
KZR
AUPH
Aurinia Reshapes C-Suite as Investor Kevin Tang Takes CEO Role Without Pay
Premium
Company Announcements
Aurinia Reshapes C-Suite as Investor Kevin Tang Takes CEO Role Without Pay
23d ago
AUPH
MKT Capital ‘applauds’ Aurinia’s management transition
Premium
The Fly
MKT Capital ‘applauds’ Aurinia’s management transition
23d ago
AUPH
Aurinia Reshapes Executive Team as Board Chair Kevin Tang Becomes CEO
PremiumCompany Announcements
Aurinia Reshapes Executive Team as Board Chair Kevin Tang Becomes CEO
23d ago
AUPH
Aurinia Pharmaceuticals announces Tang to succeed Greenleaf as CEO
PremiumThe Fly
Aurinia Pharmaceuticals announces Tang to succeed Greenleaf as CEO
23d ago
AUPH
Aurinia Pharmaceuticals Earnings Call Highlights Growth And Risks
PremiumCompany Announcements
Aurinia Pharmaceuticals Earnings Call Highlights Growth And Risks
1M ago
AUPH
Aurinia Lifts Profits on LUPKYNIS Growth and Sets Double-Digit 2026 Revenue Outlook
PremiumCompany Announcements
Aurinia Lifts Profits on LUPKYNIS Growth and Sets Double-Digit 2026 Revenue Outlook
2M ago
AUPH
Aurinia Lifts Revenue on LUPKYNIS Growth, Sets Strong 2026 Sales Outlook
PremiumCompany AnnouncementsAurinia Lifts Revenue on LUPKYNIS Growth, Sets Strong 2026 Sales Outlook
2M ago
AUPH
Aurinia Pharmaceuticals reports Q4 EPS $1.53, consensus 22c
Premium
The Fly
Aurinia Pharmaceuticals reports Q4 EPS $1.53, consensus 22c
2M ago
AUPH
Aurinia Pharmaceuticals sees 2026 revenue $315M-$-325M, consensus $326.8M
Premium
The Fly
Aurinia Pharmaceuticals sees 2026 revenue $315M-$-325M, consensus $326.8M
2M ago
AUPH
AUPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
AUPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
AUPH
Aurinia Sets February 26 Date to Report 2025 Results and Business Update
PremiumCompany Announcements
Aurinia Sets February 26 Date to Report 2025 Results and Business Update
2M ago
AUPH
Aurinia Pharmaceuticals downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
Aurinia Pharmaceuticals downgraded to Market Perform from Outperform at Leerink
4M ago
AUPH
Aurinia Pharmaceuticals downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
Aurinia Pharmaceuticals downgraded to Market Perform from Outperform at Leerink
4M ago
AUPH
Aurinia Pharmaceuticals upgraded to Buy from Hold at Jefferies
PremiumThe FlyAurinia Pharmaceuticals upgraded to Buy from Hold at Jefferies
5M ago
AUPH
Aurinia Pharmaceuticals Reports Strong Q3 2025 Earnings
Premium
Company Announcements
Aurinia Pharmaceuticals Reports Strong Q3 2025 Earnings
5M ago
AUPH
Aurinia Pharma’s Earnings Call Highlights Growth and Challenges
Premium
Company Announcements
Aurinia Pharma’s Earnings Call Highlights Growth and Challenges
5M ago
AUPH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >